Kbc Group Nv Cytek Biosciences, Inc. Transaction History

Kbc Group Nv

  • $33.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024
SELL
$4.1 - $9.51 $5,465 - $12,676
-1,333 Reduced 25.55%
3,884 $35,000
Q3 2023

Feb 15, 2024
SELL
$5.52 - $9.5 $7,358 - $12,663
-1,333 Reduced 25.55%
3,884 $21,000
Q2 2023

Feb 15, 2024
BUY
$6.69 - $11.99 $8,917 - $15,982
1,333 Added 34.32%
5,217 $45,000
Q2 2023

Jul 28, 2023
BUY
$6.69 - $11.99 $34,901 - $62,551
5,217 New
5,217 $45,000

Others Institutions Holding CTKB

# of Institutions
134
Shares Held
71.7M
Call Options Held
400
Put Options Held
0
View Full List

About Cytek Biosciences, Inc.

CTKB Quotes by TradingView
  • Ticker CTKB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 134,627,008
  • Market Cap $851M
  • Description
  • Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...
More about CTKB
Track This Portfolio

Track Kbc Group Nv Portfolio

Follow Kbc Group Nv and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kbc Group Nv, based on Form 13F filings with the SEC.

News

Stay updated on Kbc Group Nv with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email